BCIM
BSX icon

British Columbia Investment Management’s Boston Scientific BSX Stock Holding History

British Columbia Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8M Sell
204,305
-58,624
-22% -$4.69M 0.08% 191
2025
Q4 		$25.1M Buy
262,929
+50,061
+24% +$4.91M 0.13% 147
2025
Q3 		$20.8M Sell
212,868
-20,167
-9% -$2.09M 0.12% 155
2025
Q2 		$25M Sell
233,035
-48,825
-17% -$4.94M 0.15% 130
2025
Q1 		$28.4M Sell
281,860
-99,203
-26% -$9.99M 0.18% 122
2024
Q4 		$34M Sell
381,063
-124,685
-25% -$11M 0.2% 104
2024
Q3 		$42.4M Sell
505,748
-58,440
-10% -$4.61M 0.25% 76
2024
Q2 		$43.4M Sell
564,188
-683,886
-55% -$50.1M 0.26% 74
2024
Q1 		$85.5M Sell
1,248,074
-1,139,060
-48% -$73.2M 0.59% 35
2023
Q4 		$138M Buy
2,387,134
+41,234
+2% +$2.2M 1.13% 16
2023
Q3 		$124M Buy
2,345,900
+629,108
+37% +$33M 1.18% 16
2023
Q2 		$92.9M Buy
1,716,792
+1,588,697
+1,240% +$83M 0.86% 33
2023
Q1 		$6.41M Buy
128,095
+1,281
+1% +$60.4K 0.07% 229
2022
Q4 		$5.87M Sell
126,814
-14,629
-10% -$633K 0.06% 230
2022
Q3 		$5.48M Sell
141,443
-23,991
-15% -$962K 0.06% 251
2022
Q2 		$6.17M Sell
165,434
-54,558
-25% -$2.22M 0.06% 260
2022
Q1 		$9.74M Sell
219,992
-30,211
-12% -$1.31M 0.06% 254
2021
Q4 		$10.6M Sell
250,203
-12,620
-5% -$530K 0.06% 270
2021
Q3 		$11.4M Buy
262,823
+586
+0.2% +$25.9K 0.07% 251
2021
Q2 		$11.2M Sell
262,237
-127,591
-33% -$5.37M 0.07% 262
2021
Q1 		$15.1M Sell
389,828
-7,722
-2% -$292K 0.11% 179
2020
Q4 		$14.3M Sell
397,550
-5,297
-1% -$191K 0.1% 169
2020
Q3 		$15.4M Buy
402,847
+24,050
+6% +$927K 0.13% 136
2020
Q2 		$13.3M Buy
378,797
+226,166
+148% +$8.14M 0.13% 137
2020
Q1 		$4.98M Sell
152,631
-176,075
-54% -$6.88M 0.08% 204
2019
Q4 		$14.9M Buy
328,706
+137,664
+72% +$5.76M 0.11% 168
2019
Q3 		$7.77M Sell
191,042
-79,916
-29% -$3.39M 0.08% 289
2019
Q2 		$11.6M Buy
270,958
+11,964
+5% +$460K 0.1% 192
2019
Q1 		$9.94M Sell
258,994
-129,801
-33% -$4.96M 0.09% 226
2018
Q4 		$13.7M Buy
388,795
+8,313
+2% +$302K 0.12% 177
2018
Q3 		$14.6M Sell
380,482
-64,018
-14% -$2.24M 0.16% 148
2018
Q2 		$14.5M Sell
444,500
-72,125
-14% -$2.18M 0.13% 178
2018
Q1 		$14.1M Sell
516,625
-420,902
-45% -$11.4M 0.11% 219
2017
Q4 		$23.2M Buy
937,527
+356,701
+61% +$9.84M 0.16% 152
2017
Q3 		$16.9M Sell
580,826
-270,315
-32% -$7.47M 0.13% 196
2017
Q2 		$23.6M Buy
851,141
+241,372
+40% +$6.41M 0.19% 135
2017
Q1 		$15.2M Buy
609,769
+116,885
+24% +$2.84M 0.12% 206
2016
Q4 		$10.7M Buy
492,884
+98,187
+25% +$2.14M 0.09% 248
2016
Q3 		$9.39M Sell
394,697
-90,432
-19% -$2.16M 0.09% 253
2016
Q2 		$11.3M Sell
485,129
-46,704
-9% -$1.01M 0.1% 227
2016
Q1 		$10M Sell
531,833
-56,860
-10% -$999K 0.09% 249
2015
Q4 		$10.9M Sell
588,693
-18,688
-3% -$335K 0.1% 228
2015
Q3 		$9.97M Buy
607,381
+4,012
+0.7% +$68.6K 0.1% 242
2015
Q2 		$10.7M Buy
603,369
+222,862
+59% +$3.98M 0.1% 243
2015
Q1 		$6.75M Sell
380,507
-497,758
-57% -$7.87M 0.06% 365
2014
Q4 		$11.6M Buy
878,265
+1,178
+0.1% +$15.1K 0.1% 270
2014
Q3 		$10.4M Buy
877,087
+39,440
+5% +$497K 0.09% 281
2014
Q2 		$10.7M Buy
837,647
+279,641
+50% +$3.64M 0.09% 276
2014
Q1 		$7.54M Sell
558,006
-294,532
-35% -$3.87M 0.06% 341
2013
Q4 		$10.2M Sell
852,538
-44,810
-5% -$529K 0.08% 295
2013
Q3 		$10.5M Buy
897,348
+10,931
+1% +$118K 0.09% 274
2013
Q2 		$8.22M Buy
+886,417
New +$7.52M 0.07% 328

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

British Columbia Investment Management's BSX Position: Q1 2026 in Review

British Columbia Investment Management reduced its Boston Scientific (BSX) stake by 22% in Q1 2026, selling an estimated $4.69M and leaving 204,305 shares worth $12.8M. The position accounts for 0.08% of the portfolio, ranked #191.

British Columbia Investment Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $138M in Q4 2023. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • British Columbia Investment Management held 204,305 shares of Boston Scientific worth $12.8M as of Q1 2026.
  • British Columbia Investment Management sold 58,624 Boston Scientific shares in Q1 2026, an estimated $4.69M.
  • Boston Scientific made up 0.08% of British Columbia Investment Management's portfolio in Q1 2026, its #191 holding.
  • British Columbia Investment Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Boston Scientific position peaked at $138M in Q4 2023.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.